The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 22, 2014

Filed:

May. 12, 2011
Applicants:

Hiroshi Miyazaki, Osaka, JP;

Junko Tsubakimoto, Osaka, JP;

Kosuke Yasuda, Osaka, JP;

Iwao Takamuro, Osaka, JP;

Osamu Sakurai, Osaka, JP;

Tetsuya Yanagida, Osaka, JP;

Yutaka Hisada, Oskaka, JP;

Inventors:

Hiroshi Miyazaki, Osaka, JP;

Junko Tsubakimoto, Osaka, JP;

Kosuke Yasuda, Osaka, JP;

Iwao Takamuro, Osaka, JP;

Osamu Sakurai, Osaka, JP;

Tetsuya Yanagida, Osaka, JP;

Yutaka Hisada, Oskaka, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 205/04 (2006.01); C07D 207/14 (2006.01); C07D 207/16 (2006.01); C07D 207/27 (2006.01); C07D 207/327 (2006.01); C07D 207/335 (2006.01); C07D 207/34 (2006.01); C07D 211/56 (2006.01); C07D 401/04 (2006.01); C07D 401/06 (2006.01); C07D 401/10 (2006.01); C07D 401/12 (2006.01); C07D 403/06 (2006.01); C07D 403/04 (2006.01); C07D 403/10 (2006.01); C07D 405/12 (2006.01); C07D 409/06 (2006.01); C07D 409/12 (2006.01); C07D 417/04 (2006.01); C07D 417/06 (2006.01); C07D 413/12 (2006.01); A61P 5/30 (2006.01); A61P 5/18 (2006.01); C07H 15/26 (2006.01); A61K 31/5377 (2006.01); A61K 31/4545 (2006.01); A61K 31/451 (2006.01); A61K 31/427 (2006.01); A61K 31/501 (2006.01); A61K 31/506 (2006.01); A61K 31/4439 (2006.01); A61K 31/402 (2006.01); A61K 31/7056 (2006.01); A61K 31/5415 (2006.01); A61K 31/397 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to an arylalkylamine compound represented by the following formula [I] or a pharmaceutically acceptable salt thereof, a process for preparing the same, and use of the above-mentioned compound as an activating compound (CaSR agonist) of a Ca sensing receptor, a pharmaceutical composition containing the above-mentioned compound as an effective ingredient, etc.


Find Patent Forward Citations

Loading…